LCDX Stock UPDATES Lucid Inc (LCDX) 0.6200 08/03/2014 07:41:

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Lucid Inc (LCDX) 0.6200 $LCDX

Caliber Imaging & Diagnostics Completes Substantial Recapitalization
GlobeNewswire - Thu Jul 31, 3:43PM CDT
Lucid, Inc. (OTCQB:LCDX), operating as Caliber Imaging & Diagnostics, today announced that members of its Board of Directors invested $16.1 million in the Company through the purchase of its common stock at $0.55 per share. In addition, all $13.5 million of outstanding principal and interest due under the Company's Notes was converted into shares of the Company's common stock based on the same price per share.

Caliber Imaging & Diagnostics' VivaScope(R) System Featured on Boston's ABC-TV Affiliate and Ivanhoe Broadcast News
GlobeNewswire - Wed Jun 11, 6:30AM CDT
Caliber Imaging & Diagnostics (OTCQB:LCDX), formerly Lucid, Inc., was featured in two recent media reports.

VivaScan(TM) Non-Invasive 'Optical Biopsy' Comes to Beverly Hills' NIDIskin Consulting
GlobeNewswire - Mon Jun 09, 6:15AM CDT
Many people are worried about the appearance of a mole or other lesion on their skin. Those who live in California now have a new option at their disposal: VivaScan, a new procedure being offered at NIDIskin (Non-Invasive Diagnostic Imaging of the Skin) Consulting, located at 8383 Wilshire Boulevard in Beverly Hills, California.

Caliber Imaging & Diagnostics Inaugurates First Specialized VivaScope(R) Imaging Center at NIDIskin Consulting in Beverly Hills
GlobeNewswire - Mon Jun 09, 6:12AM CDT
Caliber Imaging & Diagnostics (OTCQB:LCDX), formerly Lucid, Inc., has inaugurated its new VivaScan(TM) skin imaging procedure for the general public at NIDIskin (Non-Invasive Diagnostic Imaging of the Skin) Consulting, located at 8383 Wilshire Boulevard in Beverly Hills, California.

Caliber Imaging & Diagnostics Appoints Joseph R. Williams as Its First Vice President of Global Marketing
GlobeNewswire - Wed Mar 26, 6:00AM CDT
Caliber Imaging & Diagnostics (OTCQB:LCDX), formerly Lucid, Inc., has appointed Joseph R. Williams as Vice President of Global Marketing, a newly created position, effective immediately.

Caliber Imaging & Diagnostics elects Richard C. Christopher as CFO
M2 - Fri Mar 21, 7:10AM CDT
Imaging technology company Caliber Imaging & Diagnostics (OTC BB:LCDX) reported on Thursday the appointment of Richard C. Christopher as its chief financial officer.

Caliber Imaging & Diagnostics Names Richard C. Christopher to Chief Financial Officer
GlobeNewswire - Thu Mar 20, 6:30AM CDT
Caliber Imaging & Diagnostics (OTCQB:LCDX), formerly Lucid, Inc., has named Richard C. Christopher as Chief Financial Officer, effective immediately. Mr. Christopher replaces Richard J. Pulsifer.

Caliber Imaging & Diagnostics elects Daniel Koon as director of Global Sales Support
M2 - Fri Mar 14, 6:35AM CDT
Imaging company Caliber Imaging & Diagnostics (OTC BB:LCDX) revealed on Thursday the appointment of Daniel Koon as director of its Global Sales Support, with immediate effect.

Caliber Imaging & Diagnostics Names Daniel Koon to Director of Global Sales Support
GlobeNewswire - Thu Mar 13, 8:01AM CDT
Caliber Imaging & Diagnostics (OTCQB:LCDX), formerly Lucid, Inc., has named Daniel Koon to Director of Global Sales Support, effective immediately. Mr. Koon most recently served as Caliber I.D.'s Research Sales Manager, and prior to that held other positions within the company.

Caliber Imaging & Diagnostics Names Anthony J. Roberto as Sales Manager for East Coast
GlobeNewswire - Mon Mar 10, 6:00AM CDT
Caliber Imaging & Diagnostics (OTCQB:LCDX), formerly Lucid, Inc., has named Anthony J. Roberto as East Coast Sales Manager, a newly created position. He will be focused on further developing the Company's sales initiatives for its VivaScope platform in the East Coast region of the United States.

Caliber Imaging & Diagnostics Names Robert T. Kelley to Vice President of U.S. Sales
GlobeNewswire - Wed Mar 05, 6:00AM CST
Caliber Imaging & Diagnostics (OTCQB:LCDX), formerly Lucid, Inc., has named Robert T. Kelley to Vice President of U.S. Sales, effective immediately. Mr. Kelley had served as Caliber I.D.'s Director of Clinical Sales since joining the company in November 2011.

Caliber Imaging & Diagnostics Receives $1.4 Million Order for VivaScope(R) Systems From European Distributor MAVIG GmbH
GlobeNewswire - Tue Jan 14, 6:00AM CST
Caliber Imaging & Diagnostics (OTCQB:LCDX), formerly Lucid, Inc., announces receipt of $1.4 million in orders for VivaScope systems from its European distributor MAVIG GmbH. These units are scheduled to be shipped in the first half of 2014. MAVIG has been Caliber's exclusive distributor in Europe for the past eight years.

Caliber Imaging & Diagnostics Appoints Daniel Mark Siegel, M.D. to Its Board of Directors
GlobeNewswire - Mon Jan 13, 6:00AM CST
Caliber Imaging & Diagnostics (OTCQB:LCDX), formerly Lucid, Inc., announces the appointment of Daniel Mark Siegel, M.D. to its Board of Directors, effective immediately. This increases the number of Board members to eight.

Caliber Imaging & Diagnostics Receives Orders for VivaScope Systems From Chinese Distributor ConBio (Shanghai) Co.
GlobeNewswire - Tue Jan 07, 7:00AM CST
Caliber Imaging & Diagnostics (OTCQB:LCDX), formerly Lucid, Inc., has received orders totaling $554,000 for VivaScopesystems from its Chinese distributor ConBio (Shanghai) Co., Ltd. Orders totaling $188,000 shipped in the fourth quarter of 2013, with the remaining $366,000 scheduled to be shipped in the first quarter of 2014.

Caliber Imaging & Diagnostics to Present at AdvaMed 2013: The MedTech Conference on September 24, 2013
GlobeNewswire - Thu Sep 19, 7:23AM CDT
Caliber Imaging & Diagnostics (OTCQB:LCDX), formerly Lucid, Inc., is presenting at the AdvaMed 2013: The MedTech Conference on September 24, 2013 at 9:45 AM EDT in Washington, DC.

Caliber Imaging & Diagnostics Welcomes Updated European Guideline on Basal Cell Carcinoma That Praises Confocal Microscopy
GlobeNewswire - Mon Sep 16, 7:00AM CDT
Caliber Imaging & Diagnostics (Caliber I.D.), formerly Lucid, Inc. (OTCQB:LCDX), welcomes the recent update to the Guideline on Basal Cell Carcinoma published by the European Dermatology Forum. The updated guideline identifies confocal microscopy as one of three emerging techniques in digital imaging diagnostics and reports that confocal microscopy "has shown high diagnostic accuracy for the diagnosis of basal cell carcinoma."

Caliber Imaging & Diagnostics Introduces VivaScope(R) 1500 Multilaser System
GlobeNewswire - Tue Sep 10, 8:00AM CDT
Caliber Imaging & Diagnostics (Caliber I.D.), formerly Lucid, Inc. (LCDX), has introduced the VivaScope 1500 Multilaser system, the newest device in the company's VivaScope confocal microscope product line. VivaScope Multilaser cellular imaging devices give researchers the option of a painless, noninvasive optical skin biopsy to study changes at the cellular level.

Caliber Imaging & Diagnostics Adds Two New Distributors of VivaScope(R) Devices for Brazilian and Australian/New Zealand Markets
GlobeNewswire - Thu Sep 05, 7:05AM CDT
Emdutos to Distribute VivaScope Devices in Brazil

Caliber Imaging & Diagnostics to Present at Rodman & Renshaw Annual Global Investment Conference on September 9, 2013
GlobeNewswire - Wed Sep 04, 7:20AM CDT
Caliber Imaging & Diagnostics (Caliber I.D.), formerly Lucid, Inc. (LCDX), will present at the Rodman & Renshaw Annual Global Investment Conference at 2:25 PM EDT on Monday, September 9, 2013 in New York City.

Caliber Imaging and Diagnostics Signs Strategic Advisory Agreement with H.C. Wainwright & Co.
PR Newswire - Wed Aug 28, 7:15AM CDT
Lucid, Inc. (OTBB: LCDX), d/b/a Caliber Imaging & Diagnostics (Caliber I.D.), a leader in noninvasive optical biopsies of skin and manufacturer of VivaScope® confocal imaging systems, has entered into a strategic advisory agreement with H.C. Wainwright & Co., LLC, designed to benefit the growth of Caliber I.D. as it continues to develop its business through a variety of channels.



Scroll down for more posts ▼

Top 10 Most Recent News Articles

Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 12

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 7

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 9

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 7

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 9

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 17

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading
UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 15

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading

Top 5 Most Recently Viewed Articles

Investigation Launched for Block Investors This Spring

Updated Category News Views 119

Investigation By Faruqi & Faruqi, LLP Faruqi & Faruqi, LLP, a prominent national securities litigation firm, is currently looking into issues concerning Block, Inc. (NASDAQ: SQ). The firm is focusing on claims related to alleged violations of federal securities laws that may have resulted in significant losses for investors. If you have experienced a loss of over $75,000...

Continue Reading
Aviat Networks Faces Scrutiny After Annual Report Delay

Updated Category News Views 85

Investor Concerns Escalate Amid Aviat Networks' Delay in Reporting Aviat Networks, Inc. (NASDAQ: AVNW) is facing a tough situation as its stock price suffered a notable decline, falling by $6.36, or around 26%, during intraday trading on a recent date. This drop followed the company's announcement that it would miss the deadline for filing its financial statements for the...

Continue Reading
Tarsus Pharmaceuticals Prepares to Share Q2 2025 Results

Updated Category News Views 243

Anticipating Tarsus Pharmaceuticals' Financial Report Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS) is gearing up to present its financial results for the second quarter of 2025 during a live webcast slated for Wednesday, August 6, 2025. This event will commence at 1:30 p.m. PT and 4:30 p.m. ET, providing a timely update on the company's performance and strategic...

Continue Reading
Country Garden's Stock Recovers After Debt Restructuring Efforts

Updated Category News Views 135

Country Garden’s Stock Trading Resumes with Momentum Recently, shares of Country Garden (HK: 2007), a prominent name in the Chinese property market, saw an impressive rise as trading resumed in Hong Kong after a lengthy suspension of nine months. This rebound came after the company's notable commitment to creating a debt-restructuring plan aimed at appealing to its...

Continue Reading
Unlocking Long-Term Gains: Insights from Dollar Tree's Success

Updated Category News Views 90

Dollar Tree's Remarkable Growth Over Two Decades Over the last 20 years, Dollar Tree (NASDAQ: DLTR) has become a major player in the retail market, demonstrating incredible resilience and expansion. If someone had put $1,000 into Dollar Tree stock two decades ago, that investment would have surged to more than $7,300 today. This change highlights the effectiveness of...

Continue Reading